STAT+: Men’s use of chatbots for therapy, and earnings season highlights
Reported by STAT News · all stories from statnews.com
Editorial digest
The publication examines male utilization of automated conversational agents for mental health support while summarizing key corporate financial updates. It highlights how digital behavior shifts and fiscal trends are shaping the broader digital health industry.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom11/9/2026
AI chatbots aren’t therapists. But can they finally get men to open up?
Automated conversational tools are being evaluated for their potential to help male users discuss emotional struggles.
- Trusted health newsroom11/5/2026
STAT+: As more doctors consult chatbots, health systems can block them — or buy in
Hospitals must choose whether to restrict or formally integrate conversational artificial intelligence tools increasingly utilized by physicians.
- Trusted health newsroom10/20/2026
STAT+: OpenEvidence’s JAMA paper leaves open questions
A recent journal publication regarding OpenEvidence still leaves several unanswered questions in medical technology.
- Trusted health newsroom10/13/2026
STAT+: Takeaways from an evaluation of Google’s diagnostic chatbot, AMIE
An assessment of Google's diagnostic AI chatbot, AMIE, has provided key findings.
- Trusted health newsroom11/8/2026
STAT+: Why the latest heart drug failures should make us all more skeptical of AI hype
Recent setbacks in cardiovascular medication trials highlight the need for caution regarding artificial intelligence promises in medicine.
- Trusted health newsroom10/30/2026
STAT+: FDA, CMS scramble to avoid regulatory logjam as more states look to test AI in clinical settings
Federal health agencies are working quickly to prevent oversight bottlenecks as states prepare clinical artificial intelligence trials.